1) Consider the following three firms in the Turkish pharmaceutical industry.

a)Interpret the below financial statements with respect to firm strategy and positioning, b)Calculate relevant financial performance metrics to highlight and demonstrate the differences in these firms supply chain structures and approach.

can you make the calculations and comment on it?

thank you?

Nobel llac Eczacba la Deva Holding 46,681 621.734 125,071 10,851 46,048 350,385 672.782 233,627 88,567 4.442 1,927 1,001,345 277,046 482,586 430,763 46,275 4,601 1,241,271 3,793 87.686 325,846 66,627 23,902 B.480 0 516,334 1,366,719 3,358,248 373 351,340 102.914 1,667 13,101 9,349 3,636,992 4,838,337 0 0 503,183 299 159 34,135 13,959 27,795 878,231 2,119,502 277,267 127,124 72,342 3,536 9,509 80,050 0 231,315 1,764 B.522 603 232,198 214,709 131,722 8,722 4,495 3,033 7,824 BALANCE SHEET CURRENT ASSETS Cash and Cash Equivalents Accounts Receivable Inventories Prepaid Expenses Other Current Assets Total Current Assets NON-CURRENT ASSETS Financial Investments Other Receivables Property, Plant and Equipment Intangible Assets and Goodwill Prepaid Expenses Deferred Tax Asset Other Non-Current Assets Total Non-Current Assets Total Assets CURRENT LIABILITIES Current Borrowings Current Portion of Non-Current Borrowings Accounts Payable Employee Benefit Obligations Other Payables Deferred Income Other Than Contract Liabilities Current Tax Liabilities, Current Current Provisions Other Current Liabilities Total Current Liabilities NON-CURRENT LIABILITIES Long Term Borrowing Other Payables Non-Current Provisions Deferred Tax Liabilities Total Non-Current Liabilities Total Liabilities Total Shareholders' Equity STATEMENT OF INCOME Sales Revenue Cost of Sales GROSS PROFIT General Administrative Expenses Marketing Expenses Research and Development Expense Other Income from Operating Activities Other Expenses from Operating Activities OPERATING INCOME Investment Activity Income Investment Activity Expenses Interest Income Interest Expense EARNINGS BEFORE TAX Tax Expense/Incame Deferred Tax (Expenses)/Income PROFIT LOSSI 2,352 B.501 4,697 513,652 13,357 4.786 18,157 358,554 526 67,612 7,458 670,475 269.477 92,073 25,569 20,661 407,780 921,432 445,287 17,764 19,498 4.118 161,145 202.525 561,079 4,277,258 352,713 37,666 27,806 0 418,185 1,088,660 1,030,842 1,019,641 -386,435 633,206 -77,137 -332,665 -25,824 97,194 -35485 259,289 5.954 -7.239 16,501 -103,635 170,870 -16,656 0 154,214 877,076 -561.262 315,814 -63 766 - 126,421 0 188,078 -88,799 224,906 113,610 -72,290 4,346 -77,455 193.117 -38,551 B.162 162.728 1,373,983 -654,826 719,159 -101,692 -178,857 -39,388 52,018 -24,552 426,688 2.299 -131 0 -148,161 280,695 -1.946 7,267 286,016